RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Department of Error: "Intrauterine device-related uterine perforation incidence and risk (APEX-IUD): A Large multisite cohort study"
APEX-IUD study team (2022). Department of Error: "Intrauterine device-related uterine perforation incidence and risk (APEX-IUD): A Large multisite cohort study". The Lancet, 400(10354), 732. https://doi.org/10.1016/S0140-6736(22)01645-2
Reed SD, Zhou X, Ichikawa L, et al. Intrauterine device-related uterine perforation incidence and risk (APEX-IUD): a large multisite cohort study. Lancet 2022; 399: 2103–12—In table 1 of this Article, the maximum duration of follow-up should have been 10—3 years; the number of people in the BMI category “overweight” should have been 96 181; and in the footnote marked ||, percentages should have been 15—0% for the full cohort and 6—0% for the post-partum cohort for the parity variable. These corrections have been made to the online version as of Sept 1, 2022.